Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-006905
Filing Date
2020-04-22
Accepted
2020-04-22 12:44:34
Documents
41
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 374610
2 ex31-1.htm EX-31.1 11180
3 ex31-2.htm EX-31.2 11545
4 ex32-1.htm EX-32.1 6823
5 ex32-2.htm EX-32.2 6984
  Complete submission text file 0001493152-20-006905.txt   1683490

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE accp-20190930.xml EX-101.INS 195831
7 XBRL SCHEMA FILE accp-20190930.xsd EX-101.SCH 21096
8 XBRL CALCULATION FILE accp-20190930_cal.xml EX-101.CAL 29905
9 XBRL DEFINITION FILE accp-20190930_def.xml EX-101.DEF 95945
10 XBRL LABEL FILE accp-20190930_lab.xml EX-101.LAB 137918
11 XBRL PRESENTATION FILE accp-20190930_pre.xml EX-101.PRE 130611
Mailing Address 15W155 81ST STREET BURR RIDGE IL 60527
Business Address 15W155 81ST STREET BURR RIDGE IL 60527 773-517-0789
Accelerated Pharma, Inc. (Filer) CIK: 0001630970 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-227916 | Film No.: 20807355
SIC: 2834 Pharmaceutical Preparations